Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia
Ze Chen, Jiayi Liu, Feng Zhou, et al.
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1747-1765
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
Anna Martin, Sonja Lang, Tobias Goeser, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 7, pp. 533-546
Open Access | Times Cited: 49
Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study
Laurens A. van Kleef, Zuolin Lu, M. Arfan Ikram, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 931-938
Open Access | Times Cited: 43
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
Olufunto O. Badmus, Terry D. Hinds, David E. Stec
Current Hypertension Reports (2023) Vol. 25, Iss. 8, pp. 151-162
Open Access | Times Cited: 40
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Nicholas Chew, Xin Pan, Bryan Chong, et al.
Diabetes Research and Clinical Practice (2024) Vol. 211, pp. 111652-111652
Closed Access | Times Cited: 11
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera, Javier Uribe, Nixa Olvares, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 4, pp. 101501-101501
Open Access | Times Cited: 9
Bidirectional Association between Hypertension and NAFLD: A Systematic Review and Meta-Analysis of Observational Studies
Gerui Li, Yuanyuan Peng, Ze Chen, et al.
International Journal of Endocrinology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 36
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy
Ze Chen, Zhaoxia Jin, Jingjing Cai, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 12, pp. 1721-1739
Closed Access | Times Cited: 30
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Alessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 968-968
Open Access | Times Cited: 28
Nonalcoholic fatty liver disease and non-liver comorbidities
Richie Manikat, Mindie H. Nguyen
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. Suppl, pp. s86-s102
Open Access | Times Cited: 21
The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China
Fang Lei, Juan‐Juan Qin, Xiaohui Song, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Impact of NAFLD and its pharmacotherapy on lipid profile and CVD
Zhenya Wang, Mao Ye, Xiao‐Jing Zhang, et al.
Atherosclerosis (2022) Vol. 355, pp. 30-44
Open Access | Times Cited: 24
Gut microbiota and cardiac arrhythmia
Hongxuan Fan, Xuchang Liu, Zhaoyu Ren, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 16
Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies
Yan-Lin Liao, Gen-Yuan Zhu, Cheng Chang
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 5
Socioeconomic status and public health in Australia: A wastewater-based study
Nikolaos I. Rousis, Zhe Li, Richard Bade, et al.
Environment International (2022) Vol. 167, pp. 107436-107436
Open Access | Times Cited: 21
The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
Qin Li, Junru Wu, Xuejing Sun, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12
The Pan-liver Network Theory
Yaxing Zhang, Xian-Ming Fang
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 6, pp. 401-436
Open Access | Times Cited: 12
Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease
Yao Zhang, Leigang Wang, Jiaxin Qi, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Left atrial cardiomyopathy: Pathophysiological insights, assessment methods and clinical implications
Sandro Ninni, Vincent Algalarrondo, Fabien Brette, et al.
Archives of cardiovascular diseases (2024) Vol. 117, Iss. 4, pp. 283-296
Open Access | Times Cited: 4
Sudden cardiac death associated with fatty liver disease
Jonathan Vo, Thien Tan Tri Tai Truyen, Audrey Uy‐Evanado, et al.
IJC Heart & Vasculature (2025) Vol. 56, pp. 101602-101602
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Vlad Ionescu, Gina Gheorghe, Nicolae Bacalbaşa, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 163-163
Open Access
An integrated zebrafish model and network pharmacology to investigate the mechanism of Chrysanthemum for treating metabolic dysfunction-associated fatty liver disease
Jingcheng Zhao, Jing Yang, Fei Yang, et al.
Food Chemistry (2025) Vol. 473, pp. 143134-143134
Closed Access
Metabolic dysfunction associated steatotic liver disease is associated with atrial fibrillation recurrence following cryoballoon ablation
Yu Wang, Zheng Chen, Bo Wei, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
New-Onset Atrial Fibrillation in Patients with Pacemakers and the Implications of Hepatic Impairment
Aurelian Ungureanu, Georgică Târtea, Anca Oana Docea, et al.
Life (2025) Vol. 15, Iss. 3, pp. 450-450
Open Access
Metabolic dysfunction-associated steatotic liver disease and increased risk of atrial fibrillation in the elderly: A longitudinal cohort study
Yehua Tang, Jianling Fan, Xingyun Hou, et al.
IJC Heart & Vasculature (2025) Vol. 58, pp. 101676-101676
Closed Access
Evaluation of the Electrocardiographic Tp-e, Tp-e/QT, and Tp-e/QTc Parameters in Patients with Non-Alcoholic Liver Disease
Kader Eliz Şahin, Mesut Karataş, Sezgin Barutçu, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 766-766
Open Access
Page 1 - Next Page

Scroll to top